Cargando…

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

BACKGROUND: Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the vaccine effectiveness/efficacy against persistent HPV infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donken, R., Hoes, J., Knol, M. J., Ogilvie, G. S., Dobson, S., King, A. J., Singer, J., Woestenberg, P. J., Bogaards, J. A., Meijer, C. J. L. M., de Melker, H. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341660/ https://www.ncbi.nlm.nih.gov/pubmed/32640998 http://dx.doi.org/10.1186/s12879-020-05083-7

Ejemplares similares

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
por: Donken, Robine, et al.
Publicado: (2016)

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females
por: van der Weele, Pascal, et al.
Publicado: (2019)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
por: Hoes, J., et al.
Publicado: (2021)

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
por: Donken, Robine, et al.
Publicado: (2018)

Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
por: Hoes, Joske, et al.
Publicado: (2020)

Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF(10)-DEIA-LiPA(25) (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates
por: van Eer, Kahren, et al.
Publicado: (2020)

Assessment of herd effects among women and heterosexual men after girls‐only HPV16/18 vaccination in the Netherlands: A repeated cross‐sectional study
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women
por: de Waal, Anna, et al.
Publicado: (2022)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
por: Hoes, Joske, et al.
Publicado: (2018)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Pricing of HPV vaccines in European tender-based settings
por: Qendri, Venetia, et al.
Publicado: (2018)

Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
por: Qendri, Venetia, et al.
Publicado: (2018)

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
por: Bogaards, Johannes A, et al.
Publicado: (2015)

Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients
por: Woestenberg, Petra J, et al.
Publicado: (2020)

HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV
por: McClymont, Elisabeth, et al.
Publicado: (2023)

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era
por: Prins-van Ginkel, Annemarijn C., et al.
Publicado: (2016)

Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands
por: Klooster, T. M. Schurink-van’t, et al.
Publicado: (2014)

HPV Detection Methods
por: Brink, Antoinette A. T. P., et al.
Publicado: (2007)

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection
por: Vriend, Henrike J, et al.
Publicado: (2015)

Ability of epidemiological studies to monitor HPV post-vaccination dynamics: a simulation study
por: Bonneault, Mélanie, et al.
Publicado: (2023)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt
por: Ogilvie, Gina, et al.
Publicado: (2010)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Cautious Sexual Attitudes Diminish Intent to Vaccinate Children against HPV in Utah
por: Redd, David S., et al.
Publicado: (2022)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Six-Month Incidence and Persistence of Oral HPV Infection in HIV-Negative and HIV-Infected Men Who Have Sex with Men
por: Mooij, Sofie H., et al.
Publicado: (2014)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Monitoring the impact of HPV vaccine in males—Considerations and challenges
por: Brotherton, Julia M.L., et al.
Publicado: (2016)

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands
por: Scherpenisse, Mirte, et al.
Publicado: (2012)

Computational Performance and Statistical Accuracy of *BEAST and Comparisons with Other Methods
por: Ogilvie, Huw A., et al.
Publicado: (2016)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l0vudmfi9euuq37qs48ef65iq8